Therefore, polyamines show therapeutic potential in relation to the inhibition of cancer-associated CA IX and CA XII, which is highlighted by the selectivity of natural product polyamine fragments over cytosolic off-target isoforms [42]. This evidence concerns the gene CA9 and cancer.